Acute subdural hemorrhage associated with rifampicin-induced thrombocytopenia

Neurol Sci. 2010 Apr;31(2):199-200. doi: 10.1007/s10072-009-0187-7. Epub 2009 Dec 4.

Abstract

Thrombocytopenia is a major adverse effect of several drug treatments. Rifampicin has been recognized as a cause of immune thrombocytopenia. A 68-year-old woman diagnosed with pulmonary tuberculosis was taking the standard four-drug antituberculosis regimen for 4 months. She presented with decreased responsiveness and headache. Brain MRI revealed subdural hemorrhage along the falx cerebri and high convexity. The platelet count was 8,000 microL(-1). Intracranial hemorrhage due to rifampicin-induced thrombocytopenia has not, to our knowledge, been previously reported. We report a patient with acute subdural hemorrhage associated with rifampicin-induced thrombocytopenia.

Publication types

  • Case Reports

MeSH terms

  • Acute Disease
  • Aged
  • Antitubercular Agents / adverse effects*
  • Antitubercular Agents / therapeutic use
  • Brain / pathology
  • Female
  • Hematoma, Subdural / complications*
  • Hematoma, Subdural / pathology
  • Humans
  • Magnetic Resonance Imaging
  • Rifampin / adverse effects*
  • Rifampin / therapeutic use
  • Thrombocytopenia / chemically induced*
  • Thrombocytopenia / complications*
  • Thrombocytopenia / pathology
  • Time Factors
  • Tuberculosis, Pulmonary / drug therapy

Substances

  • Antitubercular Agents
  • Rifampin